CBSET is building a 110,000-square-foot facility in Waltham with three times the capacity of its Lexington campus, opening in ...

The neuroscience-focused Seaport and blood coagulation specialist Hemab each exceeded their $200 million targets. Both begin trading Friday on the Nasdaq.

PLEASANTON, Calif., May 20, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical ...

Two veteran life-sciences investors have launched Vie Ventures, which plans to fund biotechnology startups targeting autoimmune diseases and connect them with nonprofits that might accelerate their ...

Biotechnology companies going public this week are signaling a resurgence for initial public offerings and venture-capital investment in the sector this year. Biotechs Eikon Therapeutics and ...